Common Equity: The sum of all common equity items.
Haemonetics Corporation (HAE) Common Equity data is not available for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
$330.60M |
|
$57.98M |
|
$137.55M |
|
$193.05M |
|
$259.26M |
|
$71.33M |
|
$-0.60M |
|
$70.74M |
|
$70.74M |
|
$57.98M |
|
$57.98M |
|
$57.98M |
|
$57.98M |
|
$71.33M |
|
-- |
|
49.19M |
|
49.48M |
|
$1.18 |
|
$1.17 |
|
| Balance Sheet Financials | |
$934.98M |
|
$284.05M |
|
$1.52B |
|
$2.45B |
|
$578.11M |
|
$921.23M |
|
$1.05B |
|
$1.63B |
|
|
Common Equity |
-- |
$-239.18M |
|
$820.84M |
|
-- |
|
| Cash Flow Statement Financials | |
$181.72M |
|
$-161.90M |
|
$108.82M |
|
$178.80M |
|
$306.76M |
|
$127.96M |
|
$29.64M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|